Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/18853443

Download in:

View as

General Info

PMID
18853443